Insider Buying Fuels Optimism Amid a Quiet Stock‑Price Decline Enact Holdings’ latest filing shows director Sheila Hooda purchasing 162 deferred stock units on March 19, a move that added roughly 30,700 shares to her holdings. The transaction was executed at no cash cost, reflecting the deferred‑unit structure that vests a year after her director tenure ends. While the price paid was zero, the increase in her post‑transaction stake signals confidence in Enact’s long‑term trajectory, especially as the company’s market price slipped 1.2 % in the week and 3 % for the month.
What Investors Should Take Away The buying activity occurs against a backdrop of a highly bullish social‑media pulse—Buzz at 2,712 % and a perfect sentiment score of +100. This indicates a surge of positive chatter that could be driving short‑term demand. From a fundamentals view, Enact’s P/E of 8.99 and a 17 % year‑to‑date gain suggest the stock remains fairly cheap relative to its earnings. However, the recent executive shuffle, with CFO David Wang’s exit and Michael Huang’s appointment, adds a layer of uncertainty. Investors may view the insider buying as a hedge against this transition risk, betting that the new CFO will sustain or improve operational performance.
Sheila Hooda – A Steady, Long‑Term Investor Hooda’s transaction history reveals a pattern of incremental purchases of deferred units in December and September of 2025, steadily building a position from 30,543 to 30,705 shares. Her trades are consistent, disciplined, and executed at zero cost, underscoring a belief in Enact’s future upside rather than short‑term speculation. Unlike some insiders who frequently sell or trade common stock, Hooda’s focus on deferred units signals a long‑term horizon, aligning her interests closely with the company’s strategic objectives.
Implications for the Company’s Future With a strong insider buyback in the midst of a leadership change and a stock that has already outperformed many peers, Enact Holdings sits at an inflection point. The deferred‑unit purchases reinforce management’s confidence and may help stabilize share price during the CFO transition. For shareholders, the continued insider buying provides a subtle endorsement of Enact’s mortgage‑insurance business model, suggesting that the company’s strategic direction—supported by its robust market cap and favorable P/E—remains solid. Investors should monitor the new CFO’s early performance metrics and any subsequent insider activity for signals about Enact’s trajectory over the next quarter.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-03-19 | Hooda Sheila () | Buy | 162.00 | N/A | Deferred Stock Units |
| 2026-03-19 | Gould Brian (EVP & Chief Operations Officer) | Buy | 11.00 | N/A | Restricted Stock Units |
| 2026-03-19 | Gould Brian (EVP & Chief Operations Officer) | Buy | 17.00 | N/A | Restricted Stock Units |
| 2026-03-19 | Gould Brian (EVP & Chief Operations Officer) | Buy | 21.00 | N/A | Restricted Stock Units |
| 2026-03-19 | McMullen James (Controller) | Buy | 5.00 | N/A | Restricted Stock Units |
| 2026-03-19 | McMullen James (Controller) | Buy | 7.00 | N/A | Restricted Stock Units |
| 2026-03-19 | McMullen James (Controller) | Buy | 8.00 | N/A | Restricted Stock Units |
| 2026-03-19 | McMullen James (Controller) | Buy | 14.00 | N/A | Restricted Stock Units |
| 2026-03-19 | McMullen James (Controller) | Buy | 9.00 | N/A | Restricted Stock Units |
| 2026-03-19 | Gupta Rohit (President and CEO) | Buy | 97.00 | N/A | Restricted Stock Units |
| 2026-03-19 | Gupta Rohit (President and CEO) | Buy | 158.00 | N/A | Restricted Stock Units |
| 2026-03-19 | Gupta Rohit (President and CEO) | Buy | 197.00 | N/A | Restricted Stock Units |
| 2026-03-19 | Mitchell Hardin Dean (EVP, CFO and Treasurer) | Buy | 33.00 | N/A | Restricted Stock Units |
| 2026-03-19 | Mitchell Hardin Dean (EVP, CFO and Treasurer) | Buy | 53.00 | N/A | Restricted Stock Units |
| 2026-03-19 | Mitchell Hardin Dean (EVP, CFO and Treasurer) | Buy | 69.00 | N/A | Restricted Stock Units |
| 2026-03-19 | FISK JOHN D () | Buy | 162.00 | N/A | Deferred Stock Units |
| 2026-03-19 | RESTREPO ROBERT P JR () | Buy | 162.00 | N/A | Deferred Stock Units |
| 2026-03-19 | Derstine Michael (EVP and Chief Risk Officer) | Buy | 13.00 | N/A | Restricted Stock Units |
| 2026-03-19 | Derstine Michael (EVP and Chief Risk Officer) | Buy | 21.00 | N/A | Restricted Stock Units |
| 2026-03-19 | Derstine Michael (EVP and Chief Risk Officer) | Buy | 36.00 | N/A | Restricted Stock Units |
| 2026-03-19 | STILL DEBRA () | Buy | 162.00 | N/A | Deferred Stock Units |
| 2026-03-19 | THOMPSON WESTLEY V () | Buy | 162.00 | N/A | Deferred Stock Units |
| 2026-03-19 | Addesso Dominic James () | Buy | 281.00 | N/A | Deferred Stock Units |
| N/A | Addesso Dominic James () | Holding | 24,177.00 | N/A | Deferred Stock Units |
| N/A | Addesso Dominic James () | Holding | 20,650.00 | N/A | Deferred Stock Units |
| 2026-03-19 | Stolove Evan (EVP, Gen. Counsel & Secretary) | Buy | 13.00 | N/A | Restricted Stock Units |
| 2026-03-19 | Stolove Evan (EVP, Gen. Counsel & Secretary) | Buy | 21.00 | N/A | Restricted Stock Units |
| 2026-03-19 | Stolove Evan (EVP, Gen. Counsel & Secretary) | Buy | 26.00 | N/A | Restricted Stock Units |
| 2026-03-19 | BLESS MICHAEL A () | Buy | 139.00 | N/A | Deferred Stock Units |
| 2026-03-19 | Mitchell H Elizabeth () | Buy | 30.00 | N/A | Deferred Stock Units |




